Clinical misconceptions dispelled by epidemiological research.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Circulation

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.92.11.3350PMID 7586324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Multifactorial Aetiology of Coronary Heart Disease: A Dangerous Delusion

  2015cited by this paper
• Hazards of obesity--the Framingham experience.

  2009cited by this paper
• Prevalence of intermittent claudication and its effect on mortality.

  2009cited by this paper
• Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

  1995cited by this paper
• Rational for Treatment of Hypertension in the Elderly.

  1994cited by this paper
• Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

  1994cited by this paper
• Lewis A. Conner Lecture. Contributions of epidemiology to the prevention of stroke.

  1993cited by this paper
• Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.

  1993cited by this paper
• The health benefits of exercise. A critical reappraisal.

  1993cited by this paper
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

  1993cited by this paper
• Is exercise beneficial--or hazardous--to your heart?

  1993cited by this paper
• The quality of epidemiological data in coronary heart disease and atherosclerosis.

  1993cited by this paper
• Randomized trials of warfarin for atrial fibrillation.

  1992cited by this paper
• Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women.

  1992cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• Leukocyte count and risk of major coronary heart disease events.

  1992cited by this paper
• Update on fibrinogen as a cardiovascular risk factor.

  1992cited by this paper
• White blood cell count and cardiovascular disease. Insights from the Framingham Study.

  1992cited by this paper
• Efficacy of lipid profiles in prediction of coronary disease.

  1992cited by this paper
• Left ventricular hypertrophy and mortality--results from the Framingham Study.

  1992cited by this paper
• Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study.

  1991cited by this paper
• Is hyperglycemia associated with cardiovascular disease? The Framingham Study.

  1991cited by this paper
• Probability of stroke: a risk profile from the Framingham Study.

  1991cited by this paper
• Limitations of the epidemiological method in coronary heart disease.

  1991cited by this paper
• Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies

  1991cited by this paper
• Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.

  1990cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

  1990cited by this paper
• A meta-analysis of physical activity in the prevention of coronary heart disease.

  1990cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Plasma fibrinogen and coronary risk factors: The Scottish heart health study

  1990cited by this paper
• Adiposity, fat distribution, and cardiovascular risk.

  1989cited by this paper
• Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study.

  1989cited by this paper
• Cardiac failure and sudden death in the Framingham Study.

  1988cited by this paper
• Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics.

  1988cited by this paper
• The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years.

  1987cited by this paper
• Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial.

  1987cited by this paper
• The natural history of lone atrial fibrillation. A population-based study over three decades.

  1987cited by this paper
• Atrial fibrillation and stroke in elderly hospitalized patients.

  1986cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study.

  1985cited by this paper
• Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

  1985cited by this paper
• Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.

  1985cited by this paper
• Sudden death: lessons from subsets in population studies.

  1985cited by this paper
• Plasma fibrinogen--a major coronary risk factor.

  1985cited by this paper
• Impact of age on weight goals.

  1985cited by this paper
• Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

  1984cited by this paper
• Fibrinogen as a risk factor for stroke and myocardial infarction.

  1984cited by this paper
• Coronary heart disease and atrial fibrillation: the Framingham Study.

  1983cited by this paper
• Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study.

  1983cited by this paper
• Leukocyte counts and coronary heart disease in a Japanese cohort.

  1982cited by this paper
• Epidemiologic features of chronic atrial fibrillation: the Framingham study.

  1982cited by this paper
• Labile and systolic hypertension: a reappraisal.

  1981cited by this paper
• Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study.

  1981cited by this paper
• Mortality in an insured population with atrial fibrillation.

  1981cited by this paper
• The problems of sleep-related respiratory disorders.

  1981cited by this paper
• Leukocyte count, smoking, and myocardial infarction.

  1981cited by this paper
• Labile Hypertension: A Faulty Concept? The Framingham Study

  1980cited by this paper
• W. O. Atwater memorial lecture: overweight, obesity, coronary heart disease and mortality.

  1980cited by this paper
• Perspectives on Systolic Hypertension: The Framingham Study

  1980cited by this paper
• Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

  1979cited by this paper
• Bad science and social penalties.

  1978cited by this paper
• Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group.

  1978cited by this paper
• Physical activity as an index of heart attack risk in college alumni.

  1978cited by this paper
• Is the age of unreason upon us?

  1978cited by this paper
• Is the age of unreason upon us

  1978cited by this paper
• HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study

  1977cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• Dietary cholesterol, plasma cholesterol and coronary heart disease.

  1976cited by this paper
• Risk factors and coronary heart disease--facts or fancy?

  1976cited by this paper
• The influence of obesity on health (second of two parts).

  1974cited by this paper
• The leukocyte count as a predictor of myocardial infarction.

  1974cited by this paper
• The influence of obesity on health (first of two parts).

  1974cited by this paper
• Role of diabetes in congestive heart failure: the Framingham study.

  1974cited by this paper
• Asthma: Lessons from Epidemiology

  1973cited by this paper
• The therapeutic challenge of systolic hypertension.

  1973cited by this paper
• Cardiovascular complications in diabetics.

  1973cited by this paper
• Natural history of angina pectoris in the Framingham study. Prognosis and survival.

  1972cited by this paper
• The natural history of congestive heart failure: the Framingham study.

  1971cited by this paper
• Lipid profile and the potential coronary victim.

  1971cited by this paper
• Premature mortality from coronary heart disease. The Framingham study.

  1971cited by this paper
• Intermittent Claudication: Incidence in the Framingham Study

  1970cited by this paper
• Blood pressure and risk of coronary heart disease: the Framingham study.

  1969cited by this paper
• Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

  1969cited by this paper
• Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

  1969cited by this paper
• Habitual level of physical activity and risk of coronary heart disease: the Framingham study.

  1967cited by this paper
• Ischemic Heart Disease, Atherosclerosis, and Longevity

  1966cited by this paper
• The relationship of reported coronary heart disease mortality to physical activity of work.

  1963cited by this paper
• Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years

  1963cited by this paper
• Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies.

  1962cited by this paper
• Cigarette Smoking and Coronary Heart Disease

  1962cited by this paper
• Idiopathic atrial fibrillation.

  1961cited by this paper
• Cigarette Smoking and Cardiovascular Diseases: REPORT BY THE AMERICAN HEART ASSOCIATION

  1960cited by this paper
• Influence of obesity on morbidity and mortality.

  1960cited by this paper
• Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study.

  1959cited by this paper
• Basal and supplemental blood pressures in relationship to life expectancy and hypertension symptomatology.

  1959cited by this paper
• Basal and supplemental blood pressures in relationship to life expectancy and hypertension symptomatology.

  1959cited by this paper
• II. Coronary Heart Disease in the Framingham Study

  1957cited by this paper
• Coronary heart disease in the Framingham study.

  1957cited by this paper
• Occupational Mortality in Scotland

  1957cited by this paper
• III. A Prospective Study of Degenerative Cardiovascular Disease in Albany: Report of Three Years' Experience—1. Ischemic Heart Disease

  1957cited by this paper

• Hipertrofia del ventrículo izquierdo detectada en pacientes pediátricos hospitalizados. Un resultado preocupante

  2023cites this paper
• Implementing the Guideline of the Primary Prevention of Cardiovascular Diseases in China to Daily Practice: Promoting the Transition from “Treatment-Centered” to “People's Health-Centered”

  2021cites this paper
• Framingham Heart Study

  2020cites this paper
• Framingham and North Karelia: Studies that Changed the Cardiovascular Disease Pandemic

  2018cites this paper
• Invited commentaryInvited Commentary

  2017cites this paper
• Conquering Cardiovascular Disease

  2017cites this paper
• The Trilogy of GxE: Conceptualization, Operationalization, and Application

  2016influential citation
• Prevalence of chronic compartment syndrome of the legs: Implications for clinical diagnostic criteria and therapy

  2016cites this paper
• THE PROSPECT, PROMISES AND HINDRANCES OF STATIN BASE MOLECULES: LOOK BACK TO LOOK FORWARD Review Article

  2016cites this paper
• THE PROSPECT, PROMISES AND HINDRANCES OF STATIN BASE MOLECULES: LOOK BACK TO LOOK FORWARD

  2016cites this paper
• The prevalence of preclinical atherosclerosis in a healthy adult population

  2014cites this paper
• Are Statins Reliable Drugs as Mentioned? Indications and Risks for Statins

  2014cites this paper
• Acute myocardial infarction--historical notes.

  2013cites this paper
• Uloga polimorfizama kandidatskih gena za kardiovaskularne bolesti u dugovječnosti: antropološki pristup

  2013cites this paper
• Autoimmune Liver Diseases in Canterbury, New Zealand

  2013cites this paper
• Targeting tumor cell metabolism with statins

  2012cites this paper
• Physicians’ assessment of the high blood pressure risk and their attitude towards the prevention of arterial hypertension

  2012cites this paper
• [Awareness of physicians about the causes of heart failure in hypertensive patients].

  2012cites this paper
• Sixty Years of Preventive Cardiology: A Framingham Perspective

  2011cites this paper
• Statins: Past and Present

  2011cites this paper
• Remembering William B. Kannel, MD, MPH (1923-2011).

  2011cites this paper
• Squalene monooxygenase – a target for hypercholesterolemic therapy

  2011cites this paper
• Primary Prevention of Coronary Heart Disease in Men and Women: Does 1 Size Fit All? Yes!

  2011cites this paper
• Framingham Heart Study.

  2011cites this paper
• Translational research: Lessons from past research, growing up nowadays, and development goal in future

  2011cites this paper
• Sudden cardiac death: epidemiology and risk factors

  2010cites this paper
• A literature review of the cardiovascular risk-assessment tools: applicability among Asian population

  2010cites this paper
• [Lifestyle and global cardiovascular risk: a prospective study on a borderline hypertensive population].

  2010cites this paper
• Kosteneffektivität von Pioglitazon bei Patienten mit Typ-2-Diabetes und makrovaskulären Vorerkrankungen in Deutschland

  2010cites this paper
• Some Notes on Stem Cell Therapy in Cardiovascular Diseases

  2010cites this paper
• Homocysteine and CVD risk: Is it relevant or redundant?

  2009cites this paper
• Swimming Exercise

  2009cites this paper
• Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study

  2008cites this paper
• Progressing from risk factors to omics.

  2008cites this paper
• Advances in Genetics, Proteomics, and Metabolomics Progressing From Risk Factors to Omics

  2008cites this paper
• [Cardiovascular risk factors. Insights from Framingham Heart Study].

  2008cites this paper
• Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study.

  2007cites this paper
• CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Hypertension Is Harmful to Dialysis Patients and Should Be Controlled

  2007cites this paper
• HABITOS Y ESTILOS DE VIDA ASOCIADOS A ENFERMEDADES VASCULARES EN UNIVERSITARIOS

  2007cites this paper
• The Emergence of Biobanks: Practical Design Considerations for Large Population-Based Studies of Gene-Environment Interactions

  2007cites this paper
• CHAPTER 16 – Design and Conduct of Observational Studies and Clinical Trials

  2007cites this paper
• Building Research Capacity in Pakistan: Effectiveness of an Epidemiology Training Workshop Taught By Traditional Class-Room and Video Teleconferencing Methods

  2006cites this paper
• Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease.

  2006cites this paper
• Genes, environment and the value of prospective cohort studies

  2006cites this paper
• Data density curves of B-mode ultrasound arterial wall thickness measurements in unaffected control and at-risk populations.

  2005cites this paper
• Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors

  2005cites this paper
• Lipid-lowering therapy for elderly patients at risk for coronary events and stroke.

  2005cites this paper
• High blood pressure, smoking and cardiovascular risk.

  2005cites this paper
• CARACTERÍSTICAS E RESULTADOS DO ATENDIMENTO DE PACIENTES NA UNIDADE DE HIPERTENSÃO DO HOSPITAL DAS CLÍNICAS DA FACULDADE DE MEDICINA DE RIBEIRÃO PRETO DA UNIVERSIDADE DE SÃO PAULO

  2004cites this paper
• LA HIPERTENSIÓN ARTERIAL EN LA ADOLESCENCIA. ¿CAUSAS INHERENTES AL PACIENTE O A NOSOTROS?.

  2003cites this paper
• Coronary-Event Registration and Coronary Care # 20 Registration of Coronary Events , Hot and Cold Pursuit

  2003cites this paper
• 10 Risk Factors and the Prevention of Heart Disease

  2003cites this paper
• Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

  2003cites this paper
• Risk Factors and the Prevention of Heart Disease

  2003cites this paper
• Coronary-Event Registration and Coronary Care

  2003cites this paper
• Tabaco, presión arterial y riesgo cardiovascular

  2003cites this paper
• Estrés e hipertensión arterial. Resultados del proyecto "Hacia un pesquisaje en la adolescencia de HTA (PESESCAD-HTA)"

  2002cites this paper
• Design and Conduct of Observational Studies and Clinical Trials

  2002cites this paper
• polymorphism) to the presence, extent, and severity of coronary artery disease

  2002cites this paper
• Cardiology's 10 greatest discoveries of the 20th century.

  2002cites this paper
• Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease

  2002cites this paper
• A risk-factor model of epistatic interaction, focusing on autism.

  2002cites this paper
• A Comparison Between Systolic and Diastolic Pulse Contour Analysis in the Evaluation of Arterial Stiffness

  2001cites this paper
• Endothelial Function and Cardiovascular Prevention: Role of Blood Lipids, Exercise, and Other Risk Factors

  2001cites this paper
• Risk indices: what is their value to the clinician and patient?

  2001cites this paper
• Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

  2001cites this paper
• Iron status and the risk of coronary heart disease: an example of the use of nutritional epidemiology in chronic disease research.

  2001cites this paper
• Blood pressure and cardiovascular disease: what remains to be achieved?

  2001cites this paper
• Causas predisponente y desencadenante de insuficiencia cardiaca congestiva en 400 casos

  2001cites this paper
• The prevalence and prognostic significance of electrocardiographic abnormalities.

  2000cites this paper
• The Framingham Study: ITS 50-year legacy and future promise.

  2000cites this paper
• The framingham offspring study: A commentary

  2000cites this paper
• Sudden cardiac death in heart failure.

  2000cites this paper
• Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking.

  2000cites this paper
• Poor compliance: The hidden risk factor

  2000cites this paper
• Cause-specific mortality risks of anesthesiologists. New evidence for the existence of old problems.

  2000cites this paper
• 50th anniversary historical article. The Framingham Offspring Study: a commentary.

  2000cites this paper
• Epidemiology and treatment of left ventricular hypertrophy in the elderly.

  1999cites this paper
• Food and nutrient exposures: what to consider when evaluating epidemiologic evidence.

  1999cites this paper
• Conquering cardiovascular disease: progress and promise.

  1999cites this paper
• The Framingham Offspring Study: a commentary. 1980.

  1999cites this paper
• Lipoprotein (a): an important risk factor in coronary artery disease.

  1998cites this paper
• Paroxysmal supraventricular tachycardia in the general population.

  1998cites this paper
• Cost Effectiveness of Coronary Heart Disease Prevention Strategies in Adults

  1998influential citation
• Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction.

  1998cites this paper
• Compliance with antihypertensive therapy: raising the bar of expectations.

  1998cites this paper
• Endothelial dysfunction and coronary risk reduction.

  1998cites this paper
• Preventive cardiology in the elderly.

  1997cites this paper
• Hazards, Risks, and Threats of Heart Disease from the Early Stages to Symptomatic Coronary Heart Disease and Cardiac Failure

  1997cites this paper
• Cholesterol reduction and clinical benefit. Are there limits to our expectations?

  1997cites this paper
• Registros de morbimortalidad en cardiología: metodología

  1997cites this paper
• [Registries of morbimortality in cardiology: methods].

  1997cites this paper